Related Experiment Videos
[Physostigmine--recent pharmacologic data and their significance for practical use]
Anaesthesiologie Und Reanimation
|January 1, 1989
Summary
Physostigmine effectively treats anticholinergic syndrome and aids in managing intoxication and coma. Its new analgesic properties, independent of other agonists, expand its therapeutic potential.
Area of Science:
- Pharmacology
- Neuroscience
Context:
- Physostigmine is a key treatment for central anticholinergic syndrome post-anesthesia.
- It's also used for intoxication, coma of unknown origin, and post-sedation vigilance restoration.
Purpose:
- To explore established and novel pharmacological actions of physostigmine.
- To detail its expanded therapeutic indications and mechanisms.
Summary:
- Physostigmine exhibits analgesic action via the serotoninergic system, independent of narcotic or cholinergic agonists.
- It attenuates withdrawal syndromes (alcohol, opiate, nitrous oxide) and may protect against hypoxic brain damage.
- Cardiovascular stimulation and benefits in amnestic syndromes, sleep disorders, and post-propofol anesthesia behavioral disturbances are noted.
Impact:
- Physostigmine's utility extends beyond its cholinergic effects, offering new treatment avenues.
- The drug demonstrates significant potential in managing diverse neurological and psychiatric conditions.
- Its established and emerging applications highlight its increasing clinical importance.